Unlike endogenous GLP-1, which is rapidly degraded by dipeptidyl peptidase-4, GLP-1 receptor agonists are resistant to degradation and have longer half-lives, particularly for modern long-acting agents, such as liraglutide, dulaglutide, semaglutide and tirzepatide
In research it activates melanocortin receptors MC1R (pigmentation), MC3R/MC4R (appetite, libido)
L-Carnitine injections are generally well-tolerated, but some people may experience mild side effects such as nausea, abdominal discomfort, or diarrhea
Targeting cardiovascular risk factors through dietary adaptations and caloric restriction mimetics
Phase 2 trial data shows promising efficacy but is insufficient to confirm long-term safety
Otras limitaciones que Spreckley destaca del estudio son que est basado en datos autoinformados, que suelen sobreestimar los resultados frente a los registros mdicos